Symptoms Of Lupus Erythematosus - Articles

Sort by: Newest Most Comments Relevance

Sicca symptoms in Thai patients with rheumatoid arthritis, systemic lupus erythematosus and scleroderma: a comparison with age-m by Jan Posted Fri 11 Sep 2009 4:58pm Research by Wangkaew S. and Colleague. This study was performed to determine the prevalence of ocular and oral sicca symptoms in Thai patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and scleroderma (Scl). The ocular symptoms and sign (the Schirmer's 1 test) and the oral sicca symptoms and sign (the Saxon's test Read on »

Coping with Lupus: Recognizing Symptoms of Lupus and Reducing Lupus Flare Ups by Melissa G. Patient Expert

Posted Sat 13 Sep 2008 11:47pm

1 Comment , and this is an active area of research. Common Symptoms of Lupus Painful or swollen joints and muscle pain Unexplained fever Red rashes, most commonly on the face. Chest pain upon deep... Swollen glands Extreme fatigue In some people with lupus, only one system of the body such as the skin or joints is affected. Other people experience symptoms in many parts Read on »

Learn the Symptoms of Lupus by USA.gov Posted Wed 23 May 2012 9:58am Learn the Symptoms of Lupus : Lupus can be very difficult to diagnose so it’s important to know the symptoms. Find symptoms, resources and other information about lupus. Read on »

Lupus symptoms add up quickly, don't they? by Sara G. Patient Expert

Posted Fri 30 Jul 2010 5:00am throat for a few days? I mean seriously! I'd say those add up to a whole heap of lupus, wouldn't you? I can assure you - I wasn't denying I had the symptoms - I was just... collective symptoms are a reminder that I DO have lupus, and that if I'm going to take good care of Deirdre, KitKat and the rest of the Gorman household, I need to ease up and take Read on »

UCB and Immunomedics announce positive results for epratuzumab phase IIb study in systemic lupus erythematosus (SLE) by Duane P. Patient Expert

Posted Mon 31 Aug 2009 10:08pm

1 Comment with systemic lupus. The data showed that the 12-week dose response and the dose frequency study of epratuzumab in patients with moderate to severe active lupus demonstrated a clinically meaningful treatment effect showing the drug was more effective than placebo in reducing symptoms of lupus. “The LFA congratulates UCB and Immunomedics on the positive results from Read on »

UCB and Immunomedics announce positive results for epratuzumab phase IIb study in systemic lupus erythematosus (SLE) by Wick D. Posted Mon 31 Aug 2009 6:58am with systemic lupus. The data showed that the 12-week dose response and the dose frequency study of epratuzumab in patients with moderate to severe active lupus demonstrated a clinically meaningful treatment effect showing the drug was more effective than placebo in reducing symptoms of lupus. “The LFA congratulates UCB and Immunomedics on the positive results from Read on »

Systemic lupus erythematosus (SLE) by Ahmad.H Posted Fri 03 Dec 2010 12:00am SLE is a chronic disease that causes inflammation of connective tissue. It is a multisystem autoimmune inflammatory disease. SLE is the commonest and the most serious type of lupus. What causes SLE ? SLE is believed to be an autoimmune disease, which means that the body's immune system produce antibodies that attacks the own ... Read on »

Anxiety News: Anxiety And Depression Lower Quality Of Life In Majority Of Systemic Lupus Erythematosus Patients by Katie G. Healthy Living Professional

Posted Wed 17 Jun 2009 6:31pm Anxiety And Depression Lower Quality Of Life In Majority Of Systemic Lupus Erythematosus Patients ScienceDaily (June 12, 2009) — 92.8% of patients with systemic lupus erythematosus (SLE) suffer anxiety and depression which significantly affects both their physical and emotional quality of life (QoL), according to the results of a new study presented Read on »

New Data Shows Epratuzumab Provided Significant Efficacy for Patients with Moderate to Severe Systemic Lupus Erythematosus by Duane P. Patient Expert

Posted Wed 16 Jun 2010 9:02am UCB and Immunomedics Inc. announced today that a new lupus drug candidate, epratuzumab, provided a significant reduction in disease activity in patients with moderate to severe active systemic lupus erythematosus (SLE). Findings demonstrate that in a patient population with predominantly severe disease activity, epratuzumab is improving patients Read on »

Systemic sclerosis (scleroderma) associated with discoid lupus erythematosus. by Jan Posted Sun 29 Aug 2010 12:00am Six patients with systemic sclerosis (SS) and discoid lupus erythematosus (DLE) were studied to determine whether such cases have some common clinical and laboratory... had DLE on the face and extremities. No case fulfilled criteria for systemic lupus erythematosus (SLE). The present cases with SS and DLE, but without SLE, indicate Read on »